Phase II Study of Concurrent Continuous Temozolomide (TMZ) and Tamoxifen (TMX) for Recurrent Malignant Astrocytic Gliomas

被引：0
|
作者：
Alexander M. Spence
Richard A. Peterson
Jeffrey D. Scharnhorst
Daniel L. Silbergeld
Robert C. Rostomily
机构：
[1] University of Washington,Department of Neurology, 356465
[2] University of Washington School of Medicine,Departments of Neurology and Neurological Surgery
来源：
Journal of Neuro-Oncology | 2004年 / 70卷
关键词：
anaplastic astrocytoma; glioblastoma multiforme; phase II; Tamoxifen; Temozolomide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Purpose and background: The aim of this study was to assess the frequency of response and toxicity in adults with recurrent anaplastic astrocytoma (AA) or glioblastoma multiforme (GM) treated with concurrent continuous TMZ and TMX.
引用
收藏
页码：91 / 95
页数：4
相关论文
共 50 条
  • [41] Temozolomide as First-Line Agent in Treating High-Grade Gliomas: Phase II Study
    S. Chibbaro
    L. Benvenuti
    A. Caprio
    S. Carnesecchi
    F. Pulerà
    F. Faggionato
    D. Serino
    C. Galli
    M. Andreuccetti
    N. Buxton
    R. Gagliardi
    Journal of Neuro-Oncology, 2004, 67 : 77 - 81
  • [42] Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: A relationship among efficacy, joint toxicity and anticonvulsant status
    Groves, Morris D.
    Puduvalli, Vinay K.
    Conrad, Charles A.
    Gilbert, Mark R.
    Yung, W. K. Alfred
    Jaeckle, Kurt
    Liu, Vivien
    Hess, Kenneth R.
    Aldape, Kenneth D.
    Levin, Victor A.
    JOURNAL OF NEURO-ONCOLOGY, 2006, 80 (01) : 83 - 90
  • [43] Temozolomide as first-line agent in treating high-grade gliomas:: phase II study
    Chibbaro, S
    Benvenuti, L
    Caprio, A
    Carnesecchi, S
    Pulerà, F
    Faggionato, F
    Serino, D
    Galli, C
    Andreuccetti, M
    Buxton, N
    Gagliardi, R
    JOURNAL OF NEURO-ONCOLOGY, 2004, 67 (1-2) : 77 - 81
  • [44] Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: A relationship among efficacy, joint toxicity and anticonvulsant status
    Morris D. Groves
    Vinay K. Puduvalli
    Charles A. Conrad
    Mark R. Gilbert
    W. K. Alfred Yung
    Kurt Jaeckle
    Vivien Liu
    Kenneth R. Hess
    Kenneth D. Aldape
    Victor A. Levin
    Journal of Neuro-Oncology, 2006, 80 : 83 - 90
  • [45] Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma
    Prados, MD
    Lamborn, KR
    Chang, S
    Burton, E
    Butowski, N
    Malec, M
    Kapadia, A
    Rabbitt, J
    Page, MS
    Fecloroff, A
    Xie, D
    Kelley, SK
    NEURO-ONCOLOGY, 2006, 8 (01) : 67 - 78
  • [46] Phase II Study of Single-agent Bevacizumab in Japanese Patients with Recurrent Malignant Glioma†
    Nagane, Motoo
    Nishikawa, Ryo
    Narita, Yoshitaka
    Kobayashi, Hiroyuki
    Takano, Shingo
    Shinoura, Nobusada
    Aoki, Tomokazu
    Sugiyama, Kazuhiko
    Kuratsu, Junichi
    Muragaki, Yoshihiro
    Sawamura, Yutaka
    Matsutani, Masao
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (10) : 887 - 895
  • [47] A phase II trial evaluating the effects and intra-tumoral penetration of bortezomib in patients with recurrent malignant gliomas
    Jeffrey J. Raizer
    James P. Chandler
    Roberto Ferrarese
    Sean A. Grimm
    Robert M. Levy
    Kenji Muro
    Joshua Rosenow
    Irene Helenowski
    Alfred Rademaker
    Martin Paton
    Markus Bredel
    Journal of Neuro-Oncology, 2016, 129 : 139 - 146
  • [48] A phase II trial evaluating the effects and intra-tumoral penetration of bortezomib in patients with recurrent malignant gliomas
    Raizer, Jeffrey J.
    Chandler, James P.
    Ferrarese, Roberto
    Grimm, Sean A.
    Levy, Robert M.
    Muro, Kenji
    Rosenow, Joshua
    Helenowski, Irene
    Rademaker, Alfred
    Paton, Martin
    Bredel, Markus
    JOURNAL OF NEURO-ONCOLOGY, 2016, 129 (01) : 139 - 146
  • [49] A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas
    Peereboom, David M.
    Supko, Jeffrey G.
    Carson, Kathryn A.
    Batchelor, Tracy
    Phuphanich, Surasak
    Lesser, Glenn
    Mikkelson, Tom
    Fisher, Joy
    Desideri, Serena
    He, Xiaoying
    Grossman, Stuart A.
    JOURNAL OF NEURO-ONCOLOGY, 2010, 100 (02) : 261 - 268
  • [50] Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma
    Nayak, Lakshmi
    Abrey, Lauren E.
    Drappatz, Jan
    Gilbert, Mark R.
    Reardon, David A.
    Wen, Patrick Y.
    Prados, Michael
    Deangelis, Lisa M.
    Omuro, Antonio
    LEUKEMIA & LYMPHOMA, 2013, 54 (01) : 58 - 61
12345